VolitionRx Invests in Laboratory Automation System to Increase Throughput Capacity for Large Clinical Trials
VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announced it has installed a Tecan EVO200 automated liquid handling system in its Namur, Belgium laboratory. The Tecan EVO200 is a robot that will significantly accelerate VolitionRx’s large scale clinical studies by increasing the throughput and rate of blood sample analysis by up to five times that of the current manual methods.
to read the entire article. Please